The CMCPCTH Research in Chinese Children
A Multi-centre Clinical Study of Hemorrhage Rate After Coblation Tonsillectomy in Children
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Xiaoyan Li, PHD
- Phone Number: +8618917128276
- Email: chhshent@163.com
Study Contact Backup
- Name: Hongming Xu, PHD
- Phone Number: +8613917086351
- Email: xuhongming@188.com
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200062
- Recruiting
- Children's Hospital of Shanghai
-
Contact:
- Hongming Xu, PHD
- Phone Number: +8613917086351
- Email: xuhongming@188.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- under 18 years old;
- Clear indications for tonsill surgery;
- No clear contraindications for tonsill surgery;
- Parents of the children patients accept surgical treatment;
- Parents of the children patients able to cooperate with the visit and follow-up.
Exclusion Criteria:
- Children patients with a history of adenoid or tonsillectomy surgery;
- Associated with refractory bleeding diseases;
- Combined with cleft palate;
- Down syndrome, Prader-Willi syndrome (PWS) or other chromosomal abnormalities;
- Neuromuscular diseases (including cerebral palsy);
- Other diseases that affect physical health, such as severe heart disease, kidney disease, lung disease, etc;
- Contraindications to surgery and anesthesia;
- Unable to obtain informed consent.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
hemorrhage rate after coblation tonsillectomy
Time Frame: 3 weeks after surgery
|
hemorrhage rate after coblation tonsillectomy in children within 3 weeks
|
3 weeks after surgery
|
|
risk factors of hemorrhage after coblation tonsillectomy
Time Frame: 3 weeks after surgery
|
risk factors of hemorrhage after coblation tonsillectomy in children
|
3 weeks after surgery
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Study Director: xiaoyan Li, PhD, Shanghai Children's Hospital
Publications and helpful links
General Publications
- Soderman AC, Odhagen E, Ericsson E, Hemlin C, Hultcrantz E, Sunnergren O, Stalfors J. Post-tonsillectomy haemorrhage rates are related to technique for dissection and for haemostasis. An analysis of 15734 patients in the National Tonsil Surgery Register in Sweden. Clin Otolaryngol. 2015 Jun;40(3):248-54. doi: 10.1111/coa.12361.
- Yiu Y, Mahida JB, Cooper JN, Elsey NM, Deans KJ, Minneci PC, Merrill TB, Tobias JD, Elmaraghy CA. The effect of perioperative dexamethasone dosing on post-tonsillectomy hemorrhage risk. Int J Pediatr Otorhinolaryngol. 2017 Jul;98:19-24. doi: 10.1016/j.ijporl.2017.04.033. Epub 2017 Apr 24.
- Sarny S, Ossimitz G, Habermann W, Stammberger H. Hemorrhage following tonsil surgery: a multicenter prospective study. Laryngoscope. 2011 Dec;121(12):2553-60. doi: 10.1002/lary.22347.
- Inuzuka Y, Mizutari K, Kamide D, Sato M, Shiotani A. Risk factors of post-tonsillectomy hemorrhage in adults. Laryngoscope Investig Otolaryngol. 2020 Nov 14;5(6):1056-1062. doi: 10.1002/lio2.488. eCollection 2020 Dec.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2021R096-E01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.